Funding for Nordic clinical research
The Nordic Trial Alliance (NTA) is funded by the Nordic Council of Ministers and NordForsk and seeks to increase the number of clinical multi-centre trials in the Nordic countries. The three-year pilot project is part of the Nordic Council of Minister’s “Sustainable Nordic Welfare” programme, which is targeted towards finding new, innovative solutions to renew the Nordic welfare systems.
Funding has been awarded to the following five projects:
- Assisted reproductive technology and safety in the Nordic countries, Project leader: Anja Pinborg, Denmark
- Nordic Arthroplasty Register Association - an international quality register study of total joint arthroplasty of four nations, Project leader: Keijo Mäkälä, Finland
- NordStar, Project leader: Merete Lund Hetland, Denmark
- BMT in elderly AML - a prospective, controlled, international study, Project leader: Mats Brune, Sweden
Discontinuation of infliximab therapy in patients with Crohns’ disease during sustained complete remission, Project leader: Mark Ainsworth, Denmark
Pleased with the outcome
Director of NordForsk, Gunnel Gustafsson, is very pleased with the outcome of the call.
“The grant applications were assessed by an international panel of referees, and the members were impressed with the exceptionally high level of quality of the project proposals. The funding has been awarded to studies that are of great interest and medical benefit to patients in Nordic countries and we are looking forward to following the progress of these projects,” states the director.
In line with the objectives of NTA
The NTA’s project leader Pierre Lafolie was pleased on behalf of the winning proposals and confirmed that they are in line with the overall objectives of the NTA.
“The purpose of the call was to illustrate the benefits of carrying out clinical research at the Nordic level and to show that this can speed up research activities and provide more conclusive results by drawing on larger patient groups, for example. This means that the results of a clinical trial can reach patients more rapidly,” Dr Lafolie says.
“By promoting the Nordic region as a common area for medical research we hope to reverse the current decline in the number of clinical trials. Supporting these five projects brings the NTA one step closer to reaching this goal,” concludes Pierre Lafolie.